Hepeviridae

[[File:{{{image}}}|250px|alt=|]] Authority:

Hepeviridae
Kingdom:
Phylum:
Class:
Order:
Family:	Hepeviridae

Hepeviridae is a family of viruses that includes pathogens known to infect humans and animals. The most notable member of this family is the Hepatitis E virus (HEV), which is a significant cause of viral hepatitis in humans. This family is classified under the Baltimore classification system as Group IV, which consists of positive-sense single-stranded RNA viruses.

Virology

The Hepeviridae family is characterized by non-enveloped, spherical virions with a diameter of approximately 27-34 nm. The genome is a single-stranded RNA of positive polarity, approximately 7.2 kb in length. The genome encodes three open reading frames (ORFs):

• ORF1 encodes non-structural proteins involved in viral replication, including a methyltransferase, a helicase, and an RNA-dependent RNA polymerase.
• ORF2 encodes the capsid protein, which is responsible for forming the viral capsid and is the primary target for the host immune response.
• ORF3 encodes a small phosphoprotein that plays a role in viral egress and modulation of host cell functions.

Transmission and Epidemiology

Hepatitis E virus, the most studied member of the Hepeviridae family, is primarily transmitted via the fecal-oral route, often through contaminated water. It is endemic in many developing countries with poor sanitation infrastructure. In developed countries, sporadic cases are often linked to zoonotic transmission, particularly from pigs, as HEV can infect a wide range of animal hosts.

Clinical Manifestations

In humans, HEV infection can lead to a self-limiting acute hepatitis, characterized by jaundice, fatigue, abdominal pain, and elevated liver enzymes. However, in certain populations, such as pregnant women and individuals with pre-existing liver disease, HEV infection can lead to severe outcomes, including fulminant hepatitis and death.

Diagnosis and Treatment

Diagnosis of HEV infection is typically made through serological assays detecting anti-HEV antibodies or by molecular methods such as RT-PCR to detect HEV RNA in blood or stool samples. There is no specific antiviral treatment for HEV; management is primarily supportive. A vaccine for HEV is available in some countries, but it is not widely used globally.

Also see

• Hepatitis E
• Viral hepatitis
• RNA virus
• Zoonosis

References

• Kamar, N., et al. (2012). Hepatitis E virus infection. Clinical Microbiology Reviews, 25(1), 35-51.
• Smith, D. B., et al. (2014). Proposed reference sequences for hepatitis E virus subtypes. Journal of General Virology, 95(Pt 10), 2223-2232.